动物组织中金霉素残留测定的高效液相色谱柱后衍生反应研究

建立了动物组织中金霉素残留测定的高效液相色谱柱后衍生法,研究了镁离子和草酸体系对金霉素荧光强度的影响。结果表明,镁离子浓度和草酸浓度为1∶1.2时,金霉素的荧光强度最强。动物组织样品以5%高氯酸提取,正己烷脱脂,C18净化,Hy-persil ODS C18(250×4.6 mm,5μm)分离,流动相为甲醇∶0.05 mol/L草酸=80∶20(V/V),流速为0.7 mL/min,柱后0.05 mol/L乙酸镁衍生,流速为0.1 mL/min,紫外检测器和荧光检测器同时测定,提高了金霉素残留定量灵敏度。紫外检测波长365nm,荧光检测波长eλx=360 nm,eλm=520 nm。     

鸡肉中11种喹诺酮类药物多残留的高效液相色谱检测

建立了用荧光检测器同时测定11种喹诺酮类药物(包括诺氟沙星、培氟沙星、环丙沙星、恩诺沙星、氧氟沙星、达氟沙星、洛美沙星、二氟沙星、沙拉沙星、恶喹酸和氟甲喹)在鸡肉中的多残留的高效液相色谱检测方法。鸡肉样品用10%三氯乙酸-乙腈(体积比为7∶3)提取两次并稀释,随后用反相固相萃取柱净化。采用Hypersil BDS-C18色谱柱分离,以乙腈和水为流动相梯度洗脱,荧光检测器用程序编程检测波长检测。11种喹诺酮类药物标准曲线的线性范围为5～1200 μg/L,相关系数大于0.998。在高、中、低三个添加水平下的回收率为56%～119%,批内相对标准偏差为0.4%～16.1%,批间相对标准偏差为1.4%～23.0%。检出限和定量限分别为1～23 μg/kg和4～40 μg/kg。该方法快速、灵敏,达到了兽药残留检测的要求。     

动物源性食品中五种氟喹诺酮类药物残留量的同时测定

建立了一种测定动物源性食品中5种氟喹诺酮类药物残留量的高效液相色谱法。样品经酸性乙腈提取,正己烷液-液分配净化,0.01 mol/L四丁基溴化铵溶液溶解残渣,过微孔滤膜,采用高效液相色谱附荧光检测器检测,外标法定量。氧氟沙星、环丙沙星、恩诺沙星线性范围为0.002~0.200μg/mL;诺氟沙星、达氟杀星线性范围为0.001~0.100μg/mL,5种氟喹诺酮类药物的相关系数为0.99901~0.99917。在0.002~0.040 mg/kg范围内,样品加标平均回收率在79.6%~97.5%之间,相对标准偏差为2.8%~15.3%。方法的检出限氧氟沙星、环丙沙星、恩诺沙星为0.004 mg/kg,诺氟沙星、达氟沙星为0.002 mg/kg。     

反相离子对液相色谱法同时测定11种氟喹诺酮类药物的研究

建立了高效液相色谱-荧光法同时测定11种氟喹诺酮类药物的分析方法.主要研究了流动相、流动相配比及流动相的pH对氟喹诺酮分离的影响.确定了液相色谱分析最佳条件.分离条件为:Xbridge Shield RP C18柱,以V(0.10%三氟乙酸)∶V(乙腈)∶V(甲醇)=89∶4∶7为流动相;检测波长为λex=280 nm和λem＝450 nm.方法检出限为:诺氟沙星、环丙沙星、培氟沙星和恩诺沙星0.007μg/mL,单诺沙星0.002 μg/mL,沙拉沙星和氧氟沙星为0.04 μg/mL,二氟沙星和奥比沙星为0.02 μg/mL,依诺沙星、麻保沙星为0.4 μg/mL,各组分回收率在97%～100.2%,相对标准偏差为0.2%～2.9%.     

中空纤维离心超滤-高效凝胶排阻色谱法测定青霉素V钾中蛋白杂质

建立了一种采用中空纤维离心超滤(HFCF-UF)-高效凝胶排阻色谱法(HPSEC)对青霉素V钾中的残留蛋白进行检测的方法。样品用HFCF-UF进行富集,采用HPSEC进行分析,色谱柱为TSK gel Super SW2000凝胶色谱柱(300×4.6mm,4μm),流动相为0.06mol/L NaCl-0.02mol/L NaH_2PO_4(pH=7.0),流速为0.3mL/min,紫外检测波长为220nm,柱温为室温。对照品牛血清白蛋白(BSA)在1.0~100.0μg/mL内线性关系良好(R2=0.999),回收率均大于87%,检测限为3.03ng/mL,经HFCF-UF富集处理后,富集倍数(EF)高达99倍。结果表明,该方法操作简便、结果准确、灵敏度高,为同类药物中的大分子蛋白检测提供了有效手段。     

高效液相色谱法检测六种氟喹诺酮类兽药残留前处理的优化

建立了一个检测动物源性食品中6种氟喹诺酮类药物残留的高效液相色谱方法。不同基质的样品前处理对检测影响较大:鱼、肉及肝脏等样品需经过乙腈-0.1 mol/L KH2PO4缓冲液提取,乙腈饱和的正己烷洗涤去除油脂;蛋及乳制品样品用正己烷饱和的乙腈提取,乙腈饱和的正己烷去脂。目标化合物采用高效液相色谱-荧光检测器检测,外标法定量。对市售鸡肉、猪肉、鸡蛋进行检测,添加10、20、50、100μg/kg浓度水平时,回收率在82%~105%之间,相对标准偏差在4%~12%之间,方法的检出限诺氟沙星、环丙沙星、沙拉沙星及单诺沙星为5.0μg/Kg,恩诺沙星、达氟沙星为3.0μg/Kg。     

超高效液相色谱法测定水产品中3种喹诺酮类药物残留量

提出了应用超高效液相色谱法测定水产品中诺氟沙星、环丙沙星和恩诺沙星等3种喹诺酮类药物残留量的方法。样品采用酸化乙腈提取,减压蒸干后用流动相溶解,经正己烷脱脂。以ACQUITY UPLCTMBEH C18色谱柱为分离柱,以乙腈与甲酸(0.1+99.9)溶液按体积比10比90混合作为流动相,在激发波长280nm、发射波长450nm的条件下进行荧光光度检测。3种药物的线性范围均为1.25～500μg.L-1,检出限(3S/N)均为0.1μg.kg-1,测定下限(10S/N)均为0.3μg.kg-1。以鲳鱼、对虾、河蟹等空白样品为基体做加标回收试验,测得回收率均大于80%。     

高效液相色谱法同时检测8种喹诺酮类兽药残留量

建立了吡哌酸、氧氟沙星、环丙沙星、单诺沙星、恩诺沙星、沙拉沙星、(噁)喹酸和氟甲喹8种喹诺酮类兽药残留量的高效液相色谱-荧光检测方法. 方法的线性范围: 30～2000 μg/kg, 定量限为30 μg/kg, 检出限为5 μg/kg (吡哌酸为20 μg/kg). 该方法采用基质分散和微波萃取技术进行样品的前处理, 回收率为70.0%～99.5%, 相对标准偏差1.0%～8.5%. 并同固相萃取方法进行了比较, 分别使用了RPS、HLB、MAX 3种固相萃取柱, 其回收率均低于本法. 确立了以Aglient XDB-C18 (5 μm, 150 mm×4.6mm i.d.)色谱柱, H3PO4-纯水-三乙胺-乙腈(pH 3.0)为流动相的最佳色谱条件, 吡哌酸、氧氟沙星、环丙沙星、单诺沙星、恩诺沙星、沙拉沙星的检测波长为: 激发波长285 nm, 发射波长460 nm;(噁)喹酸和氟甲喹为: 激发波长325 nm, 发射波长365 nm. 方法可满足兽药残留检测要求.     

多壁碳纳米管分子印迹固相萃取柱的制备及牛奶中三种氟喹诺酮的残留测定

建立了以恩诺沙星为假模板的多壁碳纳米管分子印迹固相萃取柱-HPLC法同时测定牛奶中三种氟喹诺酮氧氟沙星、诺氟沙星、环丙沙星残留的方法。牛奶样品经碳酸钠、乙腈沉淀蛋白后,用乙酸钠-盐酸体系调p H为3.0,经自制的多壁碳纳米管分子印迹固相萃取柱(MWCNTs-MISPE)净化萃取后,用高效液相色谱仪测定氧氟沙星、诺氟沙星、环丙沙星的含量。3种化合物在20.00-1000 ng/m L浓度范围线性关系良好,相关系数均大于0.9998,3个添加水平的回收率在82.3%-99.4%,日内和日间精密度小于20%。本文首次将自制的多壁碳纳米管分子印迹固相萃取柱应用于牛奶中的氟喹诺酮类化合物净化与富集,3份市售牛奶中氧氟沙星,诺氟沙星和环丙沙星含量均低于欧盟标准。     

咔唑-9-乙基氯甲酸酯柱前衍生胺类化合物高效液相色谱分离

采用一种新的氯甲酸酯类荧光衍生试剂咔唑-9-乙基氯甲酸酯进行柱前衍生胺类化合物并通过荧光检测的方法进行高效液相色谱(HPLC)分析。衍生物的荧光激发和发射波长为λcr／λcrs=293/365nm。色谱柱：Hypersil BDS C18柱，柱温：35℃；流速：l mL/min；流动相A为水/乙腈(20／80，V／V)，流动相B为乙腈/水(95／5，V／V)。衍生试剂用量(mol)是胺类化合物总量的3～4倍时，衍生化产率最大且恒定。该方法具有检测灵敏度高，衍生化反应简单、快速、不受样品基质盐分的干扰，尤其适合天然生物样品，食品及饲料中的胺类化合物的分析。     

Direct determination of five fluoroquinolones in chicken whole blood and in veterinary drugs by HPLC

A direct, accurate, and sensitive chromatographic analytical method for the quantitative determination of five fluoroquinolones (enoxacin, ofloxacin, norfloxacin, ciprofloxacin, and enrofloxacin) in chicken whole blood is proposed in the present study. For quantitative determination lamotrigine was used as internal standard at a concentration of 20 ng/microL. The developed method was successfully applied to the determination of enrofloxacin, as the main component of commercially available veterinary drugs. Fluoroquinolone antibiotics were separated on an Inertsil (250 x 4 mm) C8, 5 microm, analytical column, at ambient temperature. The mobile phase consisted of a mixture of citric acid (0.4 mol L(-1))-CH3OH-CH3CN (87:9:4% v/v) leading to retention times less than 14 min, at a flow rate 1.4 mL min(-1). UV detection at 275 nm provided limits of detection of 2 ng/mL per 20 microL injected volume for enoxacin, norfloxacin, and ciprofloxacin, 0.4 ng/mL for ofloxacin, and 4 ng/mL for enrofloxacin. Preparation of chicken blood samples is based on the deproteinization with acetonitrile while the pharmaceutical drug was simply diluted with water. Peaks of examined analytes in real samples were identified by means of a photodiode array detector. The method was validated in terms of within-day (n=6) precision and accuracy after chicken whole blood sample deproteinization by CH3CN. Using 50 microL of chicken blood sample, recovery rates at fortification levels of 40, 60, and 80 ng ranged from 86.7% to 103.7%. The applicability of the method was evaluated using real samples from chicken under fluoroquinolone treatment.     

Determination of fluoroquinolones in edible animal tissue samples by high performance liquid chromatography after solid phase extraction

In the present work, a rapid, accurate, and sensitive method has been developed for the quantitative determination of five fluoroquinolones (enoxacin, ofloxacin, norfloxacin, ciprofloxacin, and enrofloxacin) in edible animal tissues (muscle tissue, liver, kidney, and eggs). The separation was accomplished on an Inertsil (250 x 4 mm) C8, 5 microm, analytical column, at ambient temperature within 15 min. The mobile phase consisted of a mixture of citric acid (0.4 mol L(-1))-CH3OH-CH3CN (87:9:4% v/v). UV detection at 275 nm yielded the following limits of detection: 100 pg per 20 microL injected volume for enoxacin, norfloxacin, and ciprofloxacin, 20 pg for ofloxacin, and 200 pg for enrofloxacin. Peaks in real samples were identified by means of a photodiode array detector. The method was validated in terms of intra-day (n = 8) and inter-day (n = 8) precision and accuracy. Tissue samples were purified from endogenous interference by solid-phase extraction using Oasis HLB cartridges. The solid-phase extraction protocol was optimized in terms of retention and elution. Recovery rates at fortification levels of 40, 60, and 80 ng/g ranged from 82.5% to 111.1%. The applicability of the method was examined using real samples from a chicken treated orally with the five studied fluoroquinolones.     

Determination of fluoroquinolone antibiotics in surface waters from Mondego River by high performance liquid chromatography using a monolithic column

A novel LC-fluorescence detection method based on the use of a monolithic column for the determination of norfloxacin, ciprofloxacin, and enrofloxacin antibiotic residues in environmental waters was developed. Fluoroquinolones (FQs) were isocratically eluted using a mobile phase consisting of 0.025 M phosphoric acid solution at pH 3.0 with tetrabutylammonium and methanol (960:40, v/v) through a Chromolith Performance RP-18e column (100x4.6 mm) at a flow rate of 2.5 mL/min and detected at excitation and emission wavelengths of 278 and 450 nm, respectively. After acidification and addition of EDTA, water samples were extracted using an Oasis HLB cartridge. Linearity was evaluated in the range of 0.05 to 1 microg/mL and correlation coefficients of 0.9945 for norfloxacin, 0.9974 for ciprofloxacin, and 0.9982 for enrofloxacin were found. The limit of quantification was 25 ng/L for the three FQs. The recovery of FQs spiked into river water samples at 25, 50, and 100 ng/L fortification levels ranged from 76.5 to 91.0% for norfloxacin, 78.5 to 97.2% for ciprofloxacin, and 79.4 to 93.6% for enrofloxacin. This method was successfully applied to the analysis of water samples from the Mondego River, and ciprofloxacin and enrofloxacin residues were detected in eight water samples.     

Multiresidue determination of fluoroquinolones in shrimp by liquid chromatography-fluorescence-mass spectrometry

An efficient multiresidue method for analysis of fluoroquinolones in shrimp has been developed in which quantitation by fluorescence and confirmation by Multiple Stage Mass Spectrometry (MS) is achieved simultaneously. In this method, shrimp tissue is extracted with ammoniacal acetonitrile and the extract is defatted and then evaporated. After dissolution in basic phosphate buffer, fluoroquinolones in the extract are separated by liquid chromatography and quantitated, taking advantage of their intense fluorescence. Eluate from the fluorescence detector enters the MS, which allows for confirmation by monitoring ratios of 2 prominent product ions in the MS3 or MS2 spectrum. Using this method, 8 fluoroquinolones have been analyzed in shrimp samples fortified at 10, 25, 50, or 100 ppb levels. Recoveries for desethyleneciprofloxacin, norfloxacin, ciprofloxacin, danofloxacin, enrofloxacin, orbifloxacin, sarafloxacin, and difloxacin ranged from 75 to 92%, with relative standard deviation values of <6%. The limits of quantitation ranged from 0.1 to 1 ng/g. Enrofloxacin and ciprofloxacin were also successfully determined in enrofloxacin-incurred shrimp using this method.     

反相高效液相色谱法同时测定4种氟喹诺酮类药物在鸡可食性组织中的残留

建立了一种可同时测定鸡可食性组织中环丙沙星、达氟沙星、恩诺沙星及沙拉沙星等多种残留的反相高效液相色谱 -荧光分析法。鸡的肌肉、皮和脂、肝、肾等4种组织经不同pH值的磷酸二氢钾缓冲溶液匀浆提取,上清液通过C18固相萃 取柱净化,以流动相洗脱。洗脱液经液相色谱分离后,用荧光检测器进行检测(激发波长280 nm, 发射波长450 nm),外标 法定量。对鸡的4种组织进行添加回收率测定,结果显示方法在添加水平为20~300 μg/kg时药物的回收率约为53.9%～93.4%,批间回收率测定值的相对标准偏差低于23%;环丙沙星、恩诺沙星、沙拉沙星 的定量检出限为20 μg/kg,达氟沙星为4μg/kg。方法简单、快速,能满足常规兽药残留检测的需要。     

Screening of fluoroquinolones in environmental waters using disk-based solid-phase extraction combined to microplate fluorimetric determination and LC-MS/MS

Fluoroquinolones are in the order of the day concerning environmental contamination through anthropogenic activities, resulting in increased risk for antibiotic resistance dissemination. In this context, accessible, low-cost analytical methods are required for implementation of comprehensive surveillance and screening schemes. In this work, we propose a down-scaled disk-based solid-phase extraction system from which the eluate can be first screened by miniaturized fluorimetric reading, followed by individual determination of target fluoroquinolones (ciprofloxacin, norfloxacin, and enrofloxacin) by liquid chromatography combined to tandem mass spectrometry. The fluorimetric measurement is based on the intrinsic fluorescence of fluoroquinolones. Disk-based retention was performed after sample acidification (pH 4.0) by mixed-mode cation exchange using polystyrene divinylbenzene sulphonated sorbent. Sample loading was precisely controlled in a dedicated flow system operating at 4.0 mL min^?1. Different eluent compositions were tested, with elution performed by 1.00 mL of methanol-ammonium hydroxide (98:2, v/v), with subsequent reading of eluate in both detectors. Quantification was attained for 2–25 µg L^?1 range, with LOD values at 1 µg L^?1. The proposed approach was successfully applied to estuarine waters from the Douro River, with comparable results to a conventional SPE-LC-MS/MS procedure.     

Multiresidue determination of quinolone and fluoroquinolone antibiotics in fish and shrimp by liquid chromatography/tandem mass spectrometry

A multiresidue method was developed to measure low levels of 8 fluoroquinolones (norfloxacin, ofloxacin, danofloxacin, ciprofloxacin, desethylene ciprofloxacin, enrofloxacin, sarafloxacin, and difloxacin) and 4 quinolones (oxolinic acid, flumequine, nalidixic acid, and piromidic acid). Method detection limits range from 0.1 ng/g for quinolones to 0.4 ng/g for fluoroquinolones. Average recoveries range from 57 to 96%, depending on analyte and commodity; relative standard deviations are all less than 18%. The drugs are extracted from tissues using a mixture of ethanol and 1% acetic acid, diluted in aqueous HCI, and defatted by extraction with hexane. The compounds are further isolated using cation-exchange solid-phase extraction and measured using liquid chromatography with electrospray tandem mass spectrometry detection. The method has been evaluated and applied to the analysis of salmon, trout, and shrimp. Detectable residues were observed in 10 out of 73 samples, at concentrations ranging from 0.28 to 16 ng/g.     

Separation of fifteen quinolones by high performance liquid chromatography: application to pharmaceuticals and ofloxacin determination in urine

A simple chromatographic method is described for assaying 15 quinolones and fluoroquinolones (pipemidic acid, marbofloxacin, enoxacin, ofloxacin, norfloxacin, ciprofloxacin, danofloxacin, lomefloxacin, enrofloxacin, sarafloxacin, difloxacin, oxolinic acid, nalidixic acid, flumequine and piromidic acid), in urine and pharmaceutical samples. The determination was achieved by LC using an RP C18 analytical column. A mobile phase composed of mixtures of methanol-ACN-10 mM citrate buffer at pH 3.5 and 10 mM citrate buffer at pH 4.5, delivered under an optimum gradient program, at a flow rate of 1.5 mL/min, allows to accomplish the chromatographic separation in 26 min. For detection, diode-array UV-Vis at 280 nm and fluorescence detection set at excitation wavelength/emission wavelength: 280/450, 280/ 495, 280/405 and 320/360 nm were used. Detection and quantification limits were between 0.3-18 and 0.8-61 ng/mL, respectively. The method was validated in terms of interday (n = 6) and intraday (n = 6) precision and accuracy. The procedure was successfully applied to the analysis of human and veterinary pharmaceuticals. Also, ofloxacin was determined in human urine samples belonging to a patient undergoing treatment with this active principle, among others.     

Microwave-assisted extraction and in situ clean-up for the determination of fluoroquinolone antibiotics in chicken breast muscle by LC-MS/MS

A new method was developed for the determination of six fluoroquinolone antibiotics including fleroxacin, levofloxacin, ciprofloxacin, lomfloxacin, enrofloxacin, and sparfloxacin in chicken breast muscle, in which the extraction and clean-up were performed in one step by microwave irradiation. The mixture of ACN containing 0.3% v/v phosphoric acid/water pH 3 (70:30, v/v) was used as the extraction solution and hexane was used as the clean-up solution. The extract was analyzed by liquid chromatography-tandem mass spectrometry system. The RSDs of intra- and inter-day obtained are in the range of 1.0-10.4 and 3.8-13.6%, respectively. In the three fortified levels of chicken breast muscle (20, 100, and 500 ng/g), the recoveries of fluoroquinolone antibiotics ranging from 66.0 to 97.2% are obtained. The LODs are in the range of 2.7-6.7 ng/g. This method simplifies the process of the sample preparation and reduces the operation errors.